MiR-155 is a liposarcoma oncogene that targets casein kinase-1α and enhances β-catenin signaling.
MiR-155 is a liposarcoma oncogene that targets casein kinase-1α and enhances β-catenin signaling.
复制标题
DOI:
10.1158/0008-5472.can-11-3027
复制
发表时间:
2012-04-01
期刊:
影响因子:
11.2
通讯作者:
Lev D
中科院分区:
文献类型:
--
作者:
Zhang P;Bill K;Liu J;Young E;Peng T;Bolshakov S;Hoffman A;Song Y;Demicco EG;Terrada DL;Creighton CJ;Anderson ML;Lazar AJ;Calin GG;Pollock RE;Lev D
Liposarcoma can be an aggressive, debilitating and fatal malignancy. In this study, we identifed microRNAs (miRNAs) associated with the differentiation status of liposarcoma to gain insight into the basis for its progression. miRNA expression profiles determined in human tumors and normal fat specimens identified a de-differentiated tumor expression signature consisting of 35 miRNAs. Deregulated miRNA expression was confirmed in a second independent sample cohort. The miR-155 was the most overexpressed miRNA and functional investigations assigned an important role in the growth of de-differentiated liposarcoma cell lines. Transient or stable knockdown of miR-155 retarded tumor cell growth, decreased colony formation and induced G1-S cell cycle arrest in vitro and blocked tumor growth in murine xenografts in vivo. We identified casein kinase 1α (CK1α) as a direct target of miR-155 control which enhanced β-catenin signaling and cyclin D1 expression, promoting tumor cell growth. In summary, our results point to important functions for miR-155 and β-catenin signaling in progression of liposarcoma, revealing mechanistic vulnerabilities that might be exploited for both prognostic and therapeutic purposes.